Bronchoalveolar lavage (BAL): Klebsiella pneumoniae – Shipped May 16, 2016
A simulated bronchoalveolar lavage sample collected from a 37 year old in-patient with Hodgkin’s lymphoma and pneumonia was sent to category A laboratories.
Participants were expected to isolate and identify Klebsiella pneumoniae and report susceptibility results.
MAIN EDUCATIONAL POINTS from M161-5
- Despite emerging antimicrobial resistance in Klebsiella pneumoniae, most isolates remain susceptible to cephalosporins, aminoglycosides, trimethoprim-sulfamethoxazole and fluoroquinolones.
- Testing and reporting agents depends on the clinical setting and local antimicrobial resistance patterns of these organisms.
- CLSI has recently deleted cephalothin from the agents which should be considered for routine reporting on Enterobacteriaceae